[Federal Register Volume 65, Number 164 (Wednesday, August 23, 2000)]
[Notices]
[Pages 51327-51328]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-21501]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation 332-419]


Pricing of Prescription Drugs

AGENCY: United States International Trade Commission

ACTION: Extension of dates for delivery of the initial report and for 
written submissions by interested parties for Inv. No. 332-419, Pricing 
of Prescription Drugs.

-----------------------------------------------------------------------

EFFECTIVE DATE: August 17, 2000.
SUMMARY: In response to a request on August 9, 2000, from the Committee 
on Ways and Means (the Committee) of the United States House of 
Representatives, the Commission has extended the date for reporting the 
initial results of its investigation No. 332-419, Pricing of 
Prescription Drugs, until December 1, 2000. The deadline for written 
submissions by interested parties has been extended to September 8, 
2000.

[[Page 51328]]


FOR FURTHER INFORMATION CONTACT: Elizabeth R. Nesbitt, Project Leader 
(202-205-3355) or Raymond L. Cantrell, Deputy Project Leader (202-205-
3362), Office of Industries, or Michael Barry, Deputy Project Leader 
(202-205-3246), Office of Economics, U.S. International Trade 
Commission, Washington, DC, 20436. For information on the legal aspects 
of this investigation, contact William Gearhart of the Office of the 
General Counsel (202-205-3091). Hearing impaired individuals are 
advised that information on this matter can be obtained by contacting 
the TDD terminal on (202) 205-1810.

WRITTEN SUBMISSIONS: The deadline for written submissions has been 
extended until September 8, 2000. Interested parties are invited to 
submit written statements (original and 14 copies) concerning the 
matters to be addressed by the Commission in its report on this 
investigation. In addition to general information regarding prices and 
pricing practices prevalent in each of the countries under 
consideration, the Commission is particularly interested in comments 
regarding the question raised by the Committee in their request 
regarding the extent to which price control systems utilized by the 
countries under consideration impact pricing for comparable drugs in 
the United States. Commercial or financial information that a person 
desires the Commission to treat as confidential must be submitted on 
separate sheets of paper, each clearly marked ``Confidential Business 
Information'' at the top. All submissions requesting confidential 
treatment must conform with the requirements of Sec. 201.6 of the 
Commission's Rules of Practice and Procedure (19 CFR 201.6). All 
written submissions must conform with the provisions of section 201.8 
of the Commission's Rules. All written submissions, except for 
confidential business information, will be made available in the Office 
of the Secretary of the Commission for inspection by interested 
parties. To be assured of consideration by the Commission, written 
statements relating to the Commission's report should be submitted to 
the Commission at the earliest practical date and should be received no 
later than the close of business on September 8, 2000. All submissions 
should be addressed to the Secretary, United States International Trade 
Commission, 500 E Street SW., Washington, DC 20436. The Commission's 
rules do not authorize filing submissions with the Secretary by 
facsimile or electronic means.
    Persons with mobility impairments who will need special assistance 
in gaining access to the Commission should contact the Office of the 
Secretary at 202-205-2000. General information concerning the 
Commission may also be obtained by accessing its Internet server 
(http://www.usitc.gov). Notice of institution of the investigation was 
published in the Federal Register of July 26, 2000 (65 FR 45998).

List of Subjects

    Prescription drugs, Price controls, Compulsory licensing.

    By order of the Commission.

    Issued: August 17, 2000.
Donna R. Koehnke,
Secretary.
[FR Doc. 00-21501 Filed 8-22-00; 8:45 am]
BILLING CODE 7020-02-P